OSL
ONCOSIL FPO [OSL]
Healthcare · ASX Small Cap
$1.2600 -3.1%
Updated 22 Jul 2026 · Signals refresh every scan
Get alerts when OSL triggers a new signal
Free watchlist with daily scans for 2,200+ ASX stocks
Active Signals
Bullish Signals
- Above-average volume (1.7x) on a red day — sellers in control
- Watch out — volume is flowing out even as price holds up. Distribution pattern
- Took a hit — down 18.4% over the last 5 days
- Beating the Small Ords index — relative strength of 2.13, so it's outpacing the pack
- Trading above the 200-day average — the long-term trend is on your side
- Critical cash runway (0.9 quarters)
- Moderate P/S ratio (10.4x)
- Strong revenue growth (+222%)
- Small-cap ($20-100M)
- CANSLIM S: Tight float (49%)
- CANSLIM I: Institutional ownership (39%)
- Sentiment is mixed — no strong consensus either way
- This one has been in freefall — down 62% over the past year
- Revenue growing at +222% — the top line is moving in the right direction
- The bigger volume days are the up days — volume-weighted momentum is positive (9.38%/day)
- Beneish M-Score -1.60 > -1.78: likely earnings manipulation
- RBA hiking (-3pts)
- Calendar: Quarterly 4C in 11d (+5pts)
Risk Signals
- Not enough chatter to gauge sentiment — defaulting to neutral
Ask Scout AI about OSL
3 free messages/day · Unlimited with Pro
Recent Catalysts
HIGH OncoSil Medical Receives Saudi Arabia FDA Approval
NONE Application for quotation of securities - OSL
NONE OSPREY Registry Abstract Accepted for EANM 2026 Congress
NONE OncoSil Medical Completes Manufacturing Validation
LOW Investor Presentation
Announcement tone +3pts
Recent ASX Announcements
| 2026-07-19 | OncoSil Medical Receives Saudi Arabia FDA Approval |
| 2026-07-17 | Application for quotation of securities - OSL |
| 2026-07-14 | Investor Presentation |
| 2026-07-13 | OSPREY Registry Abstract Accepted for EANM 2026 Congress |
| 2026-07-12 | OncoSil Medical Completes Manufacturing Validation PRICE SENSITIVE |
Key Metrics
$38.9M
Market Cap
282K
Avg Volume
1.7x
Vol Ratio
$0.37 — $2.09
52-Week Range
N/A
Short Interest
N/A
Cash Runway
-208.4%
ROE
N/A
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | pass | Float: 49% |
| L | Leader vs Laggard | pass | RS: 71 |
| I | Institutional Sponsorship | pass | Inst: 39% |
| M | Market Direction | neutral | Neutral |
Sector: Healthcare
101 tickers in this sector
View all Healthcare signals →Browse all ASX tickers A–Z →Track OSL and 2,200+ ASX stocks
Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and exit management for every ASX small cap.
No credit card required